Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL26982598 | 0.95 | CA5A (0.60) | — | |
| Sulfuric Acid SCHEMBL3781859 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL6655257 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL29108649 | 0.94 | CA5A (0.75) | — | |
| Sulfuric Acid SCHEMBL11591680 | 0.94 | CA5A (0.75) | — | |
| Sulfuric Acid SCHEMBL8600720 | 0.94 | CA5A (0.75) | — | |
| Sulfuric Acid SCHEMBL6655260 | 0.94 | CA5A (0.75) | — | |
| Sulfuric Acid SCHEMBL6726094 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL11350902 | 0.94 | CA5A (0.75) | — | |
| Sulfuric Acid SCHEMBL166192 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108996531-A | A kind of production technology of pure ice crystal | 衡东合兴化工有限责任公司 | 2018-12-14 | — | — | CN | claimed |
| CN-108975369-A | A kind of production technology of pure ice crystal non-wastewater discharge | 衡东合兴化工有限责任公司 | 2018-12-11 | — | — | CN | claimed |
| CN-108862346-A | A kind of production technology of ice crystal | 衡东合兴化工有限责任公司 | 2018-11-23 | — | — | CN | claimed |
| CN-108821320-A | A kind of production technology of ice crystal non-wastewater discharge | 衡东合兴化工有限责任公司 | 2018-11-16 | — | — | CN | claimed |
| EP-0270516-B1 | PROCESS FOR THE PREPARATION OF A FRACTION CONTAINING FACTOR VIII (AHF) | IMMUNO Aktiengesellschaft (AT) | 1991-04-03 | — | — | EP | claimed |
| US-4814435-A | IMMUNOGLOBULINS | IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCH PRODUKTE (AT) | 1989-03-21 | — | — | US | claimed |
| CN-111401610-A | Forest land soil quality evaluation method integrating P L S-DEA | 中南林业科技大学 | 2020-07-10 | — | — | CN | disclosed |
| CN-106318889-B | A kind of Enterobacter bacterial strain and its application with dissolving P capacity | 云南磷化集团有限公司 | 2019-10-08 | — | — | CN | disclosed |
| CN-110087630-A | Rodlike external preparation for skin solid substrate | 日产化学株式会社 | 2019-08-02 | — | — | CN | disclosed |
| CN-109937030-A | Skin cosmetic | 日清纺控股株式会社 | 2019-06-25 | — | — | CN | disclosed |
| CN-105517529-B | Dispersion liquid and hydrogel forming method | 日产化学工业株式会社 | 2019-06-14 | — | — | CN | disclosed |
| CN-104822371-B | Hydrogel-forming material, premix, and hydrogel-forming method | 日产化学工业株式会社 | 2019-03-19 | — | — | CN | disclosed |
| CN-108996531-A | A kind of production technology of pure ice crystal | 衡东合兴化工有限责任公司 | 2018-12-14 | — | — | CN | disclosed |
| CN-102596164-A | Cosmetic, external preparation for skin, and medical instrument | NISSAN CHEMICAL IND LTD | 2012-07-18 | — | — | CN | disclosed |
| CN-1665790-A | Compositions and methods for detection and isolation of phosphorylated molecules | MOLECULAR PROBES INC (US) | 2005-09-07 | — | — | CN | disclosed |
| US-20030092684-A1 | Compositions and methods for treating hemorrhagic virus infections and other disorders | ANTIBODY SYSTEMS, INC. | 2003-05-15 | — | — | US | disclosed |
| US-20020077276-A1 | Compositions and methods for treating hemorrhagic virus infections and other disorders | ANTIBODY SYSTEMS, INC. | 2002-06-20 | — | — | US | disclosed |
| EP-1171163-A1 | COMPOSITIONS CONTAINING TETRACYCLINES FOR TREATING HEMORRHAGIC VIRUS INFECTIONS AND OTHER DISORDERS | Antibody Systems, Inc. (US) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000064479-A1 | COMPOSITIONS CONTAINING TETRACYCLINES FOR TREATING HEMORRHAGIC VIRUS INFECTIONS AND OTHER DISORDERS | ANTIBODY SYSTEMS, INC. (US) | 2000-11-02 | — | — | WO | disclosed |
| US-3932251-A | SYNTHETIC RESINS, IRRADIATION, PEPSIN | TANAKA TOMOJI | 1976-01-13 | — | — | US | disclosed |